A new consultation has been opened on the GMMMG consultations page on a draft information leaflet for inclisiran.
The draft provides additional advice and information for prescribers, and is intended to support primary care prescribers and ensure a quality standard for the prescribing of inclisiran.
The consultation will be open until 5pm on Tuesday 3rd May 2022, and comments are invited from all stakeholders.